AIRS Medical gets FDA clearance for SwiftMR with OEM AI
SwiftMR can now operate with OEM deep-learning reconstruction pipelines to add scan-time reduction or extend AI image enhancement to more MRI sequences.
AIRS Medical has received FDA 510(k) clearance for SwiftMR to operate in conjunction with deep-learning reconstruction pipelines from original equipment manufacturers.
SwiftMR is an MRI image enhancement platform designed to reduce scan times and improve image quality. AIRS Medical describes the software as vendor-neutral and FDA-cleared.
In cases where an OEM deep-learning tool is already installed, the software can provide additional scan-time reduction, according to the company. AIRS Medical said this can help imaging centers reach shorter appointment slots.
For sequences not covered by an OEM tool, SwiftMR can extend AI-powered image enhancement and scan-time reduction to additional pulse sequences and body parts, AIRS Medical said.
At one imaging center using a GE HealthCare 3T scanner with AIR Recon DL, SwiftMR reduced an already accelerated routine brain scan from 15 minutes to 9 minutes, according to the company.
Full-coverage SwiftMR has been FDA-cleared and in clinical use since 2023, AIRS Medical said. The platform is deployed at more than 1,700 imaging centers and hospitals across more than 40 countries.
SwiftMR used with OEM deep-learning reconstruction solutions is available now for imaging centers and hospitals, according to AIRS Medical.
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
More from this section
HOPPR launches mammography vision-language model
The HOPPR EB 2D Mammo Narrative Model generates structured narrative output from 2D mammography images for breast imaging workflow applications.
Philips introduces SmartIQ for Azurion coronary imaging
The coronary imaging technology adds an ultra-low-dose protocol for Philips’ Azurion image-guided therapy platform and is available in Europe and selected markets.
Rivanna receives FDA clearance for Accuro XV ultrasound
Rivanna received FDA 510(k) clearance for Accuro XV, a diagnostic ultrasound system for musculoskeletal imaging. The company is also developing AI tools for bone visualization and fracture detection.